Stay updated on Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:31:48.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T15:25:23.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Primary completion and study completion are now estimated for 2026-12-31, and enrollment is updated to 24 participants. Recent update dates (2026-02-13 and 2026-02-17) were added and an older date (2026-02-28) was removed.
    Difference
    0.3%
    Check dated 2026-02-18T07:46:37.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added; the prior funding-lapse notice (v3.4.1) was removed.
    Difference
    0.4%
    Check dated 2026-02-11T10:22:23.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added a government funding lapse notice affecting site updates and a page revision note showing version v3.4.1, replacing the previous v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T06:55:42.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Added Show glossary option and a display of Last Update Submitted that Met QC Criteria, along with a Revision: v3.4.0 and a No FEAR Act Data entry. Removed Last Update Submitted that met QC Criteria, No FEAR Act data, and the older Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T05:09:03.000Z thumbnail image

Stay in the know with updates to Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page.